Hemodialysis Market By Product and Service, By Type, By Dialysis Site : Global Opportunity Analysis and Industry Forecast, 2023-2032

Description

List of Tables

According to a new report published by Allied Market Research, titled, "Hemodialysis Market," The hemodialysis market was valued at $76.9 billion in 2022, and is estimated to reach $111.8 billion by 2032, growing at a CAGR of 3.8% from 2023 to 2032. Hemodialysis is a medical procedure used to treat individuals with end-stage renal disease (ESRD) or severe kidney dysfunction. This therapy involves the removal of waste products and excess fluids from the blood when the kidneys are no longer able to perform this vital function adequately.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Go To Market Strategy
Market share analysis of players by products/segments
New Product Development/ Product Matrix of Key Players
Additional company profiles with specific to client's interest
Average Selling Price Analysis / Price Point Analysis
Brands Share Analysis
Key player details (including location, contact details, supplier/vendor network etc. in excel format)
SWOT Analysis

Key Market Segments

By Type

Conventional Hemodialysis
Daily Hemodialysis
Nocturnal Hemodialysis

By Dialysis Site

In-center dialysis
Home dialysis

By Product and Service

Consumables
- Type
- Dialyzers
- Catheters
- Other Hemodialysis Consumables
Equipments
- Type
- Dialysis Machines
- Hemodialysis Water Treatment Systems
- Others Hemodialysis Equipment
Drugs
Services

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Baxter International Inc.
B. Braun Melsungen AG
Nipro Corporation
DaVita Inc.
Fresenius Medical Care AG & Co. KGaA
Diaverum Holding AB
Nikkiso Co., Ltd
TORAY INDUSTRIES, INC.
Asahi Kasei Corporation.
Rockwell Medical Technologies Inc.

Product Code: A04306

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Low bargaining power of suppliers
- 3.3.2. Low threat of new entrants
- 3.3.3. Low threat of substitutes
- 3.3.4. Low intensity of rivalry
- 3.3.5. Low bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Rise in prevalence of end stage renal disease (ESRD)
  - 3.4.1.2. Rise in awareness regarding hemodialysis
  - 3.4.1.3. Rise in incidence of diabetes and hypertension
  - 3.4.1.4. Shortage of kidneys for transplantation
- 3.4.2. Restraints
  - 3.4.2.1. Risks and complications associated with dialysis
- 3.4.3. Opportunities
  - 3.4.3.1. Rise in adoption of key strategy
  - 3.4.3.2. Growth opportunities in emerging economies

CHAPTER 4: HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Equipments
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.2.4. Equipments Hemodialysis Market by Type
4.3. Consumables
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.3.4. Consumables Hemodialysis Market by Type
4.4. Drugs
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
4.5. Services
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country

CHAPTER 5: HEMODIALYSIS MARKET, BY TYPE

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Conventional Hemodialysis
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Daily Hemodialysis
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Nocturnal Hemodialysis
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country

CHAPTER 6: HEMODIALYSIS MARKET, BY DIALYSIS SITE

6.1. Overview
- 6.1.1. Market size and forecast
6.2. In-center dialysis
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Home dialysis
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country

CHAPTER 7: HEMODIALYSIS MARKET, BY REGION

7.1. Overview
- 7.1.1. Market size and forecast By Region
7.2. North America
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by Product and Service
- 7.2.3. Market size and forecast, by Type
- 7.2.4. Market size and forecast, by Dialysis Site
- 7.2.5. Market size and forecast, by country
  - 7.2.5.1. U.S.
  - 7.2.5.1.1. Market size and forecast, by Product and Service
  - 7.2.5.1.2. Market size and forecast, by Type
  - 7.2.5.1.3. Market size and forecast, by Dialysis Site
  - 7.2.5.2. Canada
  - 7.2.5.2.1. Market size and forecast, by Product and Service
  - 7.2.5.2.2. Market size and forecast, by Type
  - 7.2.5.2.3. Market size and forecast, by Dialysis Site
  - 7.2.5.3. Mexico
  - 7.2.5.3.1. Market size and forecast, by Product and Service
  - 7.2.5.3.2. Market size and forecast, by Type
  - 7.2.5.3.3. Market size and forecast, by Dialysis Site
7.3. Europe
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by Product and Service
- 7.3.3. Market size and forecast, by Type
- 7.3.4. Market size and forecast, by Dialysis Site
- 7.3.5. Market size and forecast, by country
  - 7.3.5.1. Germany
  - 7.3.5.1.1. Market size and forecast, by Product and Service
  - 7.3.5.1.2. Market size and forecast, by Type
  - 7.3.5.1.3. Market size and forecast, by Dialysis Site
  - 7.3.5.2. France
  - 7.3.5.2.1. Market size and forecast, by Product and Service
  - 7.3.5.2.2. Market size and forecast, by Type
  - 7.3.5.2.3. Market size and forecast, by Dialysis Site
  - 7.3.5.3. UK
  - 7.3.5.3.1. Market size and forecast, by Product and Service
  - 7.3.5.3.2. Market size and forecast, by Type
  - 7.3.5.3.3. Market size and forecast, by Dialysis Site
  - 7.3.5.4. Italy
  - 7.3.5.4.1. Market size and forecast, by Product and Service
  - 7.3.5.4.2. Market size and forecast, by Type
  - 7.3.5.4.3. Market size and forecast, by Dialysis Site
  - 7.3.5.5. Spain
  - 7.3.5.5.1. Market size and forecast, by Product and Service
  - 7.3.5.5.2. Market size and forecast, by Type
  - 7.3.5.5.3. Market size and forecast, by Dialysis Site
  - 7.3.5.6. Rest of Europe
  - 7.3.5.6.1. Market size and forecast, by Product and Service
  - 7.3.5.6.2. Market size and forecast, by Type
  - 7.3.5.6.3. Market size and forecast, by Dialysis Site
7.4. Asia-Pacific
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by Product and Service
- 7.4.3. Market size and forecast, by Type
- 7.4.4. Market size and forecast, by Dialysis Site
- 7.4.5. Market size and forecast, by country
  - 7.4.5.1. Japan
  - 7.4.5.1.1. Market size and forecast, by Product and Service
  - 7.4.5.1.2. Market size and forecast, by Type
  - 7.4.5.1.3. Market size and forecast, by Dialysis Site
  - 7.4.5.2. China
  - 7.4.5.2.1. Market size and forecast, by Product and Service
  - 7.4.5.2.2. Market size and forecast, by Type
  - 7.4.5.2.3. Market size and forecast, by Dialysis Site
  - 7.4.5.3. Australia
  - 7.4.5.3.1. Market size and forecast, by Product and Service
  - 7.4.5.3.2. Market size and forecast, by Type
  - 7.4.5.3.3. Market size and forecast, by Dialysis Site
  - 7.4.5.4. India
  - 7.4.5.4.1. Market size and forecast, by Product and Service
  - 7.4.5.4.2. Market size and forecast, by Type
  - 7.4.5.4.3. Market size and forecast, by Dialysis Site
  - 7.4.5.5. South Korea
  - 7.4.5.5.1. Market size and forecast, by Product and Service
  - 7.4.5.5.2. Market size and forecast, by Type
  - 7.4.5.5.3. Market size and forecast, by Dialysis Site
  - 7.4.5.6. Rest of Asia-Pacific
  - 7.4.5.6.1. Market size and forecast, by Product and Service
  - 7.4.5.6.2. Market size and forecast, by Type
  - 7.4.5.6.3. Market size and forecast, by Dialysis Site
7.5. LAMEA
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by Product and Service
- 7.5.3. Market size and forecast, by Type
- 7.5.4. Market size and forecast, by Dialysis Site
- 7.5.5. Market size and forecast, by country
  - 7.5.5.1. Brazil
  - 7.5.5.1.1. Market size and forecast, by Product and Service
  - 7.5.5.1.2. Market size and forecast, by Type
  - 7.5.5.1.3. Market size and forecast, by Dialysis Site
  - 7.5.5.2. Saudi Arabia
  - 7.5.5.2.1. Market size and forecast, by Product and Service
  - 7.5.5.2.2. Market size and forecast, by Type
  - 7.5.5.2.3. Market size and forecast, by Dialysis Site
  - 7.5.5.3. South Africa
  - 7.5.5.3.1. Market size and forecast, by Product and Service
  - 7.5.5.3.2. Market size and forecast, by Type
  - 7.5.5.3.3. Market size and forecast, by Dialysis Site
  - 7.5.5.4. Rest of LAMEA
  - 7.5.5.4.1. Market size and forecast, by Product and Service
  - 7.5.5.4.2. Market size and forecast, by Type
  - 7.5.5.4.3. Market size and forecast, by Dialysis Site

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

9.1. Baxter International Inc.
- 9.1.1. Company overview
- 9.1.2. Key executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.1.7. Key strategic moves and developments
9.2. B. Braun Melsungen AG
- 9.2.1. Company overview
- 9.2.2. Key executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
9.3. Asahi Kasei Corporation.
- 9.3.1. Company overview
- 9.3.2. Key executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
9.4. DaVita Inc.
- 9.4.1. Company overview
- 9.4.2. Key executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.4.7. Key strategic moves and developments
9.5. Nikkiso Co., Ltd
- 9.5.1. Company overview
- 9.5.2. Key executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
9.6. Nipro Corporation
- 9.6.1. Company overview
- 9.6.2. Key executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
- 9.6.7. Key strategic moves and developments
9.7. Fresenius Medical Care AG & Co. KGaA
- 9.7.1. Company overview
- 9.7.2. Key executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business performance
- 9.7.7. Key strategic moves and developments
9.8. Diaverum Holding AB
- 9.8.1. Company overview
- 9.8.2. Key executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Key strategic moves and developments
9.9. Rockwell Medical Technologies Inc.
- 9.9.1. Company overview
- 9.9.2. Key executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
- 9.9.7. Key strategic moves and developments
9.10. TORAY INDUSTRIES, INC.
- 9.10.1. Company overview
- 9.10.2. Key executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- 9.10.7. Key strategic moves and developments